Global RNA-Targeted Small Molecules Market Size, Status and Forecast 2024-2034
Global RNA-Targeted Small Molecules Scope and Market Size
RNA-Targeted Small Molecules market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNA-Targeted Small Molecules market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
mRNA Translation Regulation
RNA Splicing Modification
Direct RNA Targeting
Indirect RNA Targeting - Epitranscriptomics
Segment by Application
Hospitals
Laboratories
Phamacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Accent Therapeutics
Anima Biotech Inc.
Arrakis Pharmaceuticals
Epics Therapeutics
Expansion Therapeutics
Gotham Therapeutics
H3 Biomedicine
Ribometrix
Skyhawk Therapeutics
STORM Therapeutics
Twentyeight-Seven Therapeutics

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 mRNA Translation Regulation
1.2.3 RNA Splicing Modification
1.2.4 Direct RNA Targeting
1.2.5 Indirect RNA Targeting - Epitranscriptomics
1.3 Market by Application
1.3.1 Global RNA-Targeted Small Molecules Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Phamacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global RNA-Targeted Small Molecules Market Perspective (2016-2027)
2.2 RNA-Targeted Small Molecules Growth Trends by Regions
2.2.1 RNA-Targeted Small Molecules Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 RNA-Targeted Small Molecules Historic Market Share by Regions (2016-2021)
2.2.3 RNA-Targeted Small Molecules Forecasted Market Size by Regions (2022-2027)
2.3 RNA-Targeted Small Molecules Industry Dynamic
2.3.1 RNA-Targeted Small Molecules Market Trends
2.3.2 RNA-Targeted Small Molecules Market Drivers
2.3.3 RNA-Targeted Small Molecules Market Challenges
2.3.4 RNA-Targeted Small Molecules Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA-Targeted Small Molecules Players by Revenue
3.1.1 Global Top RNA-Targeted Small Molecules Players by Revenue (2016-2021)
3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2016-2021)
3.2 Global RNA-Targeted Small Molecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by RNA-Targeted Small Molecules Revenue
3.4 Global RNA-Targeted Small Molecules Market Concentration Ratio
3.4.1 Global RNA-Targeted Small Molecules Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-Targeted Small Molecules Revenue in 2020
3.5 RNA-Targeted Small Molecules Key Players Head office and Area Served
3.6 Key Players RNA-Targeted Small Molecules Product Solution and Service
3.7 Date of Enter into RNA-Targeted Small Molecules Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-Targeted Small Molecules Breakdown Data by Type
4.1 Global RNA-Targeted Small Molecules Historic Market Size by Type (2016-2021)
4.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2022-2027)
5 RNA-Targeted Small Molecules Breakdown Data by Application
5.1 Global RNA-Targeted Small Molecules Historic Market Size by Application (2016-2021)
5.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America RNA-Targeted Small Molecules Market Size (2016-2027)
6.2 North America RNA-Targeted Small Molecules Market Size by Type
6.2.1 North America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
6.2.2 North America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
6.2.3 North America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
6.3 North America RNA-Targeted Small Molecules Market Size by Application
6.3.1 North America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
6.3.2 North America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
6.3.3 North America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
6.4 North America RNA-Targeted Small Molecules Market Size by Country
6.4.1 North America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
6.4.2 North America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe RNA-Targeted Small Molecules Market Size (2016-2027)
7.2 Europe RNA-Targeted Small Molecules Market Size by Type
7.2.1 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2021)
7.2.2 Europe RNA-Targeted Small Molecules Market Size by Type (2022-2027)
7.2.3 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2027)
7.3 Europe RNA-Targeted Small Molecules Market Size by Application
7.3.1 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2021)
7.3.2 Europe RNA-Targeted Small Molecules Market Size by Application (2022-2027)
7.3.3 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2027)
7.4 Europe RNA-Targeted Small Molecules Market Size by Country
7.4.1 Europe RNA-Targeted Small Molecules Market Size by Country (2016-2021)
7.4.2 Europe RNA-Targeted Small Molecules Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific RNA-Targeted Small Molecules Market Size (2016-2027)
8.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type
8.2.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2021)
8.2.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2022-2027)
8.2.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2027)
8.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application
8.3.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2021)
8.3.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2022-2027)
8.3.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2027)
8.4 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region
8.4.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2016-2021)
8.4.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America RNA-Targeted Small Molecules Market Size (2016-2027)
9.2 Latin America RNA-Targeted Small Molecules Market Size by Type
9.2.1 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
9.2.2 Latin America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
9.2.3 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
9.3 Latin America RNA-Targeted Small Molecules Market Size by Application
9.3.1 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
9.3.2 Latin America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
9.3.3 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
9.4 Latin America RNA-Targeted Small Molecules Market Size by Country
9.4.1 Latin America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
9.4.2 Latin America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA-Targeted Small Molecules Market Size (2016-2027)
10.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type
10.2.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2021)
10.2.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2022-2027)
10.2.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2027)
10.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application
10.3.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2021)
10.3.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2022-2027)
10.3.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2027)
10.4 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country
10.4.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2016-2021)
10.4.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Accent Therapeutics
11.1.1 Accent Therapeutics Company Details
11.1.2 Accent Therapeutics Business Overview
11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Introduction
11.1.4 Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.1.5 Accent Therapeutics Recent Development
11.2 Anima Biotech Inc.
11.2.1 Anima Biotech Inc. Company Details
11.2.2 Anima Biotech Inc. Business Overview
11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Introduction
11.2.4 Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.2.5 Anima Biotech Inc. Recent Development
11.3 Arrakis Pharmaceuticals
11.3.1 Arrakis Pharmaceuticals Company Details
11.3.2 Arrakis Pharmaceuticals Business Overview
11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Introduction
11.3.4 Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.3.5 Arrakis Pharmaceuticals Recent Development
11.4 Epics Therapeutics
11.4.1 Epics Therapeutics Company Details
11.4.2 Epics Therapeutics Business Overview
11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Introduction
11.4.4 Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.4.5 Epics Therapeutics Recent Development
11.5 Expansion Therapeutics
11.5.1 Expansion Therapeutics Company Details
11.5.2 Expansion Therapeutics Business Overview
11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Introduction
11.5.4 Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.5.5 Expansion Therapeutics Recent Development
11.6 Gotham Therapeutics
11.6.1 Gotham Therapeutics Company Details
11.6.2 Gotham Therapeutics Business Overview
11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Introduction
11.6.4 Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.6.5 Gotham Therapeutics Recent Development
11.7 H3 Biomedicine
11.7.1 H3 Biomedicine Company Details
11.7.2 H3 Biomedicine Business Overview
11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Introduction
11.7.4 H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.7.5 H3 Biomedicine Recent Development
11.8 Ribometrix
11.8.1 Ribometrix Company Details
11.8.2 Ribometrix Business Overview
11.8.3 Ribometrix RNA-Targeted Small Molecules Introduction
11.8.4 Ribometrix Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.8.5 Ribometrix Recent Development
11.9 Skyhawk Therapeutics
11.9.1 Skyhawk Therapeutics Company Details
11.9.2 Skyhawk Therapeutics Business Overview
11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Introduction
11.9.4 Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.9.5 Skyhawk Therapeutics Recent Development
11.10 STORM Therapeutics
11.10.1 STORM Therapeutics Company Details
11.10.2 STORM Therapeutics Business Overview
11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Introduction
11.10.4 STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.10.5 STORM Therapeutics Recent Development
11.11 Twentyeight-Seven Therapeutics
11.11.1 Twentyeight-Seven Therapeutics Company Details
11.11.2 Twentyeight-Seven Therapeutics Business Overview
11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Introduction
11.11.4 Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
11.11.5 Twentyeight-Seven Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details